Global Cell Therapy Market Expected to Reach USD 60.8 Billion by 2033 - IMARC Group

November 14, 2024 | Healthcare

VIEW FULL TABLE OF CONTENTS

Global Cell Therapy Market Statistics, Outlook and Regional Analysis 2025-2033

The global cell therapy market size was valued at USD 15.7 Billion in 2024, and it is expected to reach USD 60.8 Billion by 2033, exhibiting a growth rate (CAGR) of 14.51% from 2025 to 2033.

Cell Therapy Market

To get more information on this market, Request Sample

The cell therapy market continues to evolve with substantial advancements driven by research, innovation, and increased accessibility. On the contrary, institutions and companies worldwide are prioritizing investments in R&D activities to develop transformative therapies aimed at addressing critical health issues, including cancer, autoimmune diseases, and chronic infections. A strong trend is evident in the form of collaborative efforts between academia, industry, and medical centers to create solutions that are not only innovative but also cost-effective. For instance, in April 2024, the President of India launched the country's first home-grown CAR-T cell therapy for cancer at IIT Bombay. This breakthrough symbolizes the 'Make in India' and 'Atmanirbhar Bharat' initiatives, developed in collaboration with Tata Memorial Hospital and ImmunoACT. Furthermore, this development represents a significant milestone in making life-saving cancer treatments affordable and accessible, signaling a major shift in the approach to advanced medical care. Also, the global expansion of dedicated research hubs for cell therapy has further amplified this momentum. For instance, in November 2024, MD Anderson Cancer Center inaugurated its Institute for Cell Therapy Discovery & Innovation, backed by over US$80 Million in support. In addition, the institute will extensive clinical and research expertise to develop impactful cell therapies. The institute is set to drive innovative solutions from preclinical studies through clinical trials, creating new treatment opportunities with its mission to address unmet needs in cancer and other diseases. Meanwhile, advancements in cell handling technology are enhancing the infrastructure supporting this growth. In November 2024, iotaSciences launched its single-cell cloning platform XT at the Cell 2024 event in London. This state-of-the-art platform, featuring proprietary fluid-shaping technology and the new SCAI system, automates single-cell isolation and monoclonal culture development. This innovation strengthens the research capabilities essential for the development of personalized and scalable cell and gene therapies by improving efficiency and accuracy, positioning the industry for further growth in addressing complex medical challenges.

Global Cell Therapy Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America dominates the cell therapy market due to its robust research infrastructure, high investment in biotechnology, and supportive regulatory environment.

North America Cell Therapy Market Trends:

North America is the dominating region in the cell therapy market, which is driven by advanced healthcare facilities, and renowned research institutions that drive innovation. For instance, in March 2024, the U.S. FDA approved Bristol Myers Squibb’s Breyanzi (liso-cel), the first CAR T cell therapy for adults with relapsed or refractory CLL or SLL, showcasing the region's leadership in cutting-edge treatments. This milestone underscores North America's ability to deliver personalized, high-impact medical solutions that address complex health issues. The presence of significant funding, skilled workforce, and collaborations between industry and academia continues to strengthen the region's position as a leader in cell therapy advancements.

Europe Cell Therapy Market Trends:

In Europe, the market focuses on regulatory support and innovation in stem cell research. Countries like Germany are leading with advanced R&D activities and collaborations between biotech firms and academic institutions. Also, the region prioritizes therapies for degenerative diseases and cancer, promoting personalized medicine. For instance, the European Medicines Agency's support for the development of CAR-T cell therapies reinforces Europe's commitment to groundbreaking medical solutions.

Asia Pacific Cell Therapy Market Trends:

Asia Pacific sees rapid growth in cell therapy due to increasing government investments and partnerships. Japan, under its regenerative medicine laws, encourages innovative treatments, including CAR-T therapies and stem cell research. Companies like Takeda are at the forefront of developing cell-based treatments. The region’s focus on advancing infrastructure and supportive policies bolsters the cell therapy market significantly.

Latin America Cell Therapy Market Trends:

Latin America is gradually expanding its cell therapy market, driven by emerging research hubs and international collaborations. Brazil leads in stem cell research, with local initiatives pushing for wider clinical applications. Institutes and universities play a key role in developing cost-effective, locally tailored therapies to address specific regional health challenges, boosting both accessibility and market potential in the region.

Middle East and Africa Cell Therapy Market Trends:

The Middle East and Africa region is witnessing steady growth in cell therapy, propelled by partnerships with global biotech firms and new medical facilities. The UAE, for instance, invests in cutting-edge healthcare technology and stem cell research to enhance treatment options. These investments support the development and accessibility of innovative cell therapies despite challenges related to infrastructure and funding in some areas.

Top Companies Leading in the Cell Therapy Industry

Some of the leading cell therapy market companies include AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd, and Vericel Corporation., among many others. In July 2023, AlloSource received FDA 510(K) clearance for AceConnex pre-sutured fascia for hip labral reconstruction and augmentation. Moreover, Holostem Terapie Avanzate S.r.l signed a contract for the transfer of the business branch of Holoclar, an autologous stem-cell therapy for the treatment of patients with severe ocular surface burns, with Chiesi Farmaceutici, an international research-focused group (Chiesi Group).

Global Cell Therapy Market Segmentation Coverage

On the basis of the cell type, the market has been bifurcated into stem cell (bone marrow, blood, umbilical cord-derived, adipose-derived stem cell, and others) and non-stem cell, wherein stem cell represents the most preferred segment. Stem cells, with their remarkable regenerative potential and ability to differentiate into various cell types, have garnered significant attention in the medical field.
Based on the therapy type, the market is categorized into autologous and allogeneic, amongst which autologous dominates the market. Autologous therapies involve the extraction, manipulation, and reinfusion of a patient's cells, minimizing the risk of rejection and adverse reactions.
On the basis of the therapeutic area, the market has been divided into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others. Among these, malignancies exhibit a clear dominance in the market. Malignancies, including various types of cancer, present one of the most challenging healthcare concerns globally. Cell therapies, such as CAR-T, have emerged as groundbreaking treatments for these conditions.
Based on the end user, the market is bifurcated into hospitals and clinics and academic and research institutes. Hospitals and clinics play a critical role in administering cell therapy to patients, ensuring practical application. In contrast, academic and research institutes drive innovation, conducting essential R&D to develop new, effective cell-based treatments.

Report Features	Details
Market Size in 2024	USD 15.7 Billion
Market Forecast in 2033	USD 60.8 Billion
Market Growth Rate (2025-2033)	14.51%
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: Cell Type Therapy Type Therapeutic Area End User Region
Cell Types Covered	Stem Cell: Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Others Non-stem Cell
Therapy Types Covered	Autologous, Allogeneic
Therapeutic Areas Covered	Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Others
End Users Covered	Hospitals and Clinics, Academic and Research Institutes
Regions Covered	Asia Pacific, Europe, North America, Latin America, the Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd, Vericel Corporation, etc.
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Browse IMARC Related Reports on Cell Therapy Market Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Cell Therapy Market Expected to Reach USD 60.8 Billion by 2033 - IMARC Group

Purchase Options New Year Sale

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.